1. Home
2. ICD-10 Codes
3. Chapter - R00-R99
4. Section - R97
5. Category - R97
6. R97.21

R97.21 - Rising PSA following treatment for malignant neoplasm of prostate

• Applicable to Rising PSA following treatment for malignant neoplasm of prostate
• The 2025 edition of ICD10-CM R97.21 became effective on October 1, 2024.
• This is the American ICD10-CM version of R97.21 - other international versions of ICD10 R97.21 may differ.
• R97.21 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

The following codes above R97.21 contain annotation back-references that may be applicable to R97.21:

• Chapter: R00-R99 - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
• Section: R97 - Abnormal tumor markers
• Category: R97 - Abnormal tumor markers

Browse other similar CM codes:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.